Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension ; volume:23 ; number:1 ; day:30 ; month:8 ; year:2022 ; pages:1-12 ; date:12.2022
Respiratory research ; 23, Heft 1 (30.8.2022), 1-12, 12.2022
- Urheber
-
Zhou, Jingjing
Li, FuRong
Yang, Yicheng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-022-02137-z
- URN
-
urn:nbn:de:101:1-2022111721190702042414
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhou, Jingjing
- Li, FuRong
- Yang, Yicheng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pulmonary arterial hypertension
The Protective Role of PPARgamma in Pulmonary Arterial Hypertension
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
Pulmonary Arterial Hypertension and Pregnancy
Arrhythmias in pulmonary arterial hypertension
P5.24: Pulmonary Arterial Hypertension and Arterial Stiffness
CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
MnTBAP reverses pulmonary vascular remodeling and improves cardiac function in experimentally induced pulmonary arterial hypertension
Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension
Novel biomarkers for pulmonary arterial hypertension
Cellular mechanosignaling in pulmonary arterial hypertension
Pulmonary arterial hypertension
The Protective Role of PPARgamma in Pulmonary Arterial Hypertension
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
Pulmonary Arterial Hypertension and Pregnancy
Arrhythmias in pulmonary arterial hypertension
P5.24: Pulmonary Arterial Hypertension and Arterial Stiffness
CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
MnTBAP reverses pulmonary vascular remodeling and improves cardiac function in experimentally induced pulmonary arterial hypertension
Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension
Novel biomarkers for pulmonary arterial hypertension
Cellular mechanosignaling in pulmonary arterial hypertension
Pulmonary arterial hypertension
The Protective Role of PPARgamma in Pulmonary Arterial Hypertension
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
Pulmonary Arterial Hypertension and Pregnancy
Arrhythmias in pulmonary arterial hypertension
P5.24: Pulmonary Arterial Hypertension and Arterial Stiffness
CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
MnTBAP reverses pulmonary vascular remodeling and improves cardiac function in experimentally induced pulmonary arterial hypertension
Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension
Novel biomarkers for pulmonary arterial hypertension